A Phase 1, Randomized, Double-Blind, Single-Dose, Placebo-Controlled Safety, Tolerability, And Pharmacokinetic/Pharmacodynamic Study Of Evolocumab In Healthy Chinese Subjects

• Váldodahkkit: Liu C (Dahkki), Lu H (Dahkki), Yuan F (Dahkki), Chen WL (Dahkki), Xu HR (Dahkki), Li H (Dahkki), Hsu CP (Dahkki), Egbuna O (Dahkki), Wu J (Dahkki), Dias C (Dahkki), Abosaleem B (Dahkki), Rana J (Dahkki), Monsalvo ML (Dahkki), Li XN (Dahkki), Yu Z (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Dove Medical Press, 2019-10-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Chao Liu,1 Hong Lu,2 Fei Yuan,1 Wei-Li Chen,1 Hong-Rong Xu,1 Hui Li,1 Cheng-Pang Hsu,3 Ogo Egbuna,3 Jihua Wu,2 Clapton Dias,3 Bassam Abosaleem,3 Jitesh Rana,3 Maria Laura Monsalvo,3 Xue-Ning Li,1 Zhigang Yu4 1Department of Clinical Pharmacology, Zhongshan Hospital, Fudan University, Shanghai, People...